Gastroenterology Unit, Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.
Neurogastroenterol Motil. 2019 Mar;31(3):e13531. doi: 10.1111/nmo.13531. Epub 2019 Jan 10.
Anhedonia is the lowered ability to experience pleasure from rewarding or enjoyable activities and is considered a symptom of depression. Inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) are frequently accompanied by psychiatric disorders such as depression. However, to our knowledge, studies have yet to investigate the anhedonia in these patients. Our aim was to study the level of anhedonia in patients with IBD and IBS in comparison with healthy controls (HC), and to relate anhedonia levels with the severity of abdominal pain.
We consecutively recruited IBD and IBS patients. All patients fulfilled the Snaith-Hamilton Pleasure Scale (SHAPS), a self-rating scale consisting of 14 items that cover the domains of social interaction, food, and drink, sensory experiences, achievement and pastimes, and the Beck Depression Inventory-II (BDI-II) to screen for depression. Moreover, we calculated abdominal pain on a (0-100) Visual Analog Scale (VAS) in all patients.
We enrolled 120 patients (64 IBD and 56 IBS) and 81 HC. Among IBD patients, 34 had Crohn's disease and 30 ulcerative colitis. All patients as a whole had significantly higher SHAPS and BDI-II scores than HC (1.3 ± 1.5 vs 0.8 ± 0.1; P = 0.01 and 10.4 ± 7.5 vs 5.9 ± 4.9; P < 0.001, respectively), while no significant differences were found among groups. SHAPS score showed a significant correlation in only a few statements of BDI-II. In our cohort, a multivariate regression analysis showed that SHAPS score was significantly related to current abdominal pain (0-100 VAS) (P = 0.03) independent of gender and age.
The level of anhedonia was higher in all patients compared to healthy controls. The more the subject is anhedonic, the higher the VAS scale for abdominal pain. This study suggests that anhedonia would need to be very carefully weighed in IBD and IBS patients.
快感缺失是指体验奖励或愉悦活动的能力降低,被认为是抑郁症的一种症状。炎症性肠病(IBD)和肠易激综合征(IBS)常伴有抑郁等精神障碍。然而,据我们所知,这些患者的快感缺失尚未得到研究。我们的目的是研究 IBD 和 IBS 患者与健康对照组(HC)相比的快感缺失水平,并将快感缺失水平与腹痛严重程度相关联。
我们连续招募了 IBD 和 IBS 患者。所有患者均完成了 Snaith-Hamilton 快感量表(SHAPS),这是一个自我评估量表,由 14 个项目组成,涵盖社交互动、食物和饮料、感官体验、成就和娱乐以及贝克抑郁量表-II(BDI-II)等领域,用于筛查抑郁。此外,我们在所有患者中计算了(0-100)视觉模拟量表(VAS)的腹痛。
我们共纳入了 120 名患者(64 名 IBD 和 56 名 IBS)和 81 名 HC。在 IBD 患者中,34 名患有克罗恩病,30 名患有溃疡性结肠炎。所有患者的 SHAPS 和 BDI-II 评分均显著高于 HC(1.3±1.5 与 0.8±0.1;P=0.01 和 10.4±7.5 与 5.9±4.9;P<0.001),而组间无显著差异。SHAPS 评分仅与 BDI-II 的少数几项陈述有显著相关性。在我们的队列中,多元回归分析显示,SHAPS 评分与当前腹痛(0-100 VAS)显著相关(P=0.03),与性别和年龄无关。
与健康对照组相比,所有患者的快感缺失水平均较高。患者越快感缺失,VAS 腹痛评分越高。这项研究表明,在 IBD 和 IBS 患者中,快感缺失需要非常仔细地考虑。